Literature DB >> 6781602

Clinical pharmacology. Drug monitoring.

D C Moir.   

Abstract

Mesh：

Year:  1981        PMID： 6781602      PMCID： PMC1504470          DOI： 10.1136/bmj.282.6264.632

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  7 in total

1.  Untoward effects associated with practolol administration: oculomucocutaneous syndrome.

Authors:  P Wright
Journal:  Br Med J       Date:  1975-03-15

2.  A hospital based drug information system.

Authors:  D C Moir; E R Alexander; J W Barnett; L J Christopher
Journal:  Health Bull (Edinb)       Date:  1975-03

3.  Drug surveillance utilizing nurse monitors. An epidemiological approach.

Authors:  D Slone; H Jick; I Borda; T C Chalmers; M Feinleib; H Muench; L Lipworth; C Bellotti; B Gilman
Journal:  Lancet       Date:  1966-10-22       Impact factor: 79.321

4.  International aspects of drug monitoring. Role of the World Health Organization.

Authors:  B W Royall
Journal:  WHO Chron       Date:  1971-10

5.  Monitoring adverse reactions to drugs.

Authors:  C T Dollery; M D Rawlins
Journal:  Br Med J       Date:  1977-01-08

6.  Debendox and congenital malformations in Northern Ireland.

Authors:  D W Harron; K Griffiths; R G Shanks
Journal:  Br Med J       Date:  1980-11-22

7.  Frequency of eye complaints and rashes among patients receiving practolol and propranolol.

Authors:  D C Skegg; R Doll
Journal:  Lancet       Date:  1977-09-03       Impact factor: 79.321
  7 in total
  4 in total

1.  Evaluation of a prescription based record-linkage model for epidemiological studies of long-term adverse effects of drugs--with special regard to combined oral contraceptives.

Authors:  I Persson; H O Adami; S E Norell; B Westerholm; B E Wiholm
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 2.  Development of new drugs in man: a review.

Authors:  I B Davies; I M Grind; A Pottage; P Turner
Journal:  J R Soc Med       Date:  1986-02       Impact factor: 5.344

Review 3.  The way towards adverse event monitoring in clinical trials.

Authors:  M A Wallander
Journal:  Drug Saf       Date:  1993-03       Impact factor: 5.606

4.  Cohort study of oestrogen treatment and the risk of endometrial cancer: evaluation of method and its applicability.

Authors:  I Persson; H O Adami; E Johansson; B Lindberg; P Manell; B Westerholm
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.